Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Physical Activity (PF10 Sub Domain of SF-36 Activity Score) and Tolerability in COPD Patients During Treatment With Spiriva® Respimat®

NCT00699699 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00699699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00699699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Physical Activity (PF10 Sub Domain of SF-36 Activity Score) and Tolerability in COPD Patients During Treatment With Spiriva® Respimat®
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
Not reported
Enrollment
1,280 (actual)
Sites
188

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive